http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102131775-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5da9ef6c28994f379e69b07babaad8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2009-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4deacc497aa5fe8dac629f0336e85265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3c593d066b5eada202c2ba944a2e776
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_966d48ac8231eaa9854146f129a83f3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1353719c9ec63a649cc88fa573f77f61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a2a9a914b50c0b8fd3a1356f697ec35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d51e9e1c2baa88ae3b2748f921458157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0cd1b9699aa1b6c988684c16446f4c7
publicationDate 2011-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102131775-A
titleOfInvention Small molecule inhibitors of androgen receptor N-terminal activation
abstract The present invention provides compounds having the structure of formula A. The use of these compounds for the treatment of various indications, including prostate cancer, and methods of treatment involving these compounds are provided. Also provided are the use of compounds having the structure of formula F for the treatment of various indications, including prostate cancer, and methods of treatment involving these compounds.
priorityDate 2008-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467860055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466372571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467100908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466807842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147856331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409248912

Total number of triples: 38.